⌘K

Login Start Free

Home/Filings/4/0001209191-16-088803

4//SEC Filing

EAGLE PHARMACEUTICALS, INC. 4

Accession 0001209191-16-088803

CIK 0000827871operating

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:51 PM ET

Size

5.4 KB

Accession

0001209191-16-088803

Insider Transaction Report

Form 4

Period: 2016-01-04

EAGLE PHARMACEUTICALS, INC.EGRX

Director

Transactions

Award
Stock Option (right to buy)
2016-01-04+15,000→ 15,000 total
Exercise: $86.15Exp: 2026-01-03→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]The option fully vests on January 4, 2017, subject to the reporting person's continuous service with the issuer as of the vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000827871

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 4:51 PM ET
Size: 5.4 KB

View on SEC.gov